Commission Decision of 29 June 2007 establishing the BSE status of Member States or third countries or regions thereof according to their BSE risk (notified under document number C(2007) 3114) (Text with EEA relevance) (2007/453/EC)

Article 1 U.K.

[F1 (1)] The BSE status of countries or regions according to their BSE risk is set out in the Annex.

[F2 (2) However, the official United Kingdom BSE status for England, Northern Ireland, Scotland and Wales is categorised by reference to the website of the OIE, as amended from time to time.]

Textual Amendments

F1 Art. 1 renumbered as Art. 1(1) (31.12.2020) by The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(2)(a); 2020 c. 1, Sch. 5 para. 1(1)

F2 Art. 1(2) inserted (31.12.2020) by The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(2)(b); 2020 c. 1, Sch. 5 para. 1(1)

Article 2 U.K.

This Decision shall apply from 1 July 2007.

F3 Article 3 U.K.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments

F3 Art. 3 omitted (31.12.2020) by virtue of The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(3); 2020 c. 1, Sch. 5 para. 1(1)